Palisade Bio Quote - PALI

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.7501

Bid

1.50

Offer

2.19

Volume

124,371

1.75 Day's Range 1.86

1.38 52 Week Range 22.35

Market Cap

2.327M

Previous Close

1.80

Open

1.79

Last Trade

900

1.7501

(formt)

Last Trade Time

Financial Volume

US$ 225,175

VWAP

1.8105

Average Volume (3m)

1,315,325

Shares Outstanding

1,329,516

Dividend Yield

PE Ratio

-0.16

Earnings Per Share (EPS)

-9.25

Revenue

250k

Net Profit

-12.3M

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.palisadebio.com.

Headquarters

Camden, Delaware, USA

Founded

Palisade Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PALI. The last closing price for Palisade Bio was US$1.80. Over the last year, Palisade Bio shares have traded in a share price range of US$ 1.38 to US$ 22.35.

Palisade Bio currently has 1,329,516 shares in issue. The market capitalisation of Palisade Bio is US$2.39 million. Palisade Bio has a price to earnings ratio (PE ratio) of -0.16.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.4429	-20.1960784314	2.193	2.35	1.61	773600	1.80605939	CS
4	-0.7099	-28.8577235772	2.46	3.3	1.38	3837198	2.31397452	CS
12	-1.6499	-48.5264705882	3.4	4.318	1.38	1315325	2.3506735	CS
26	-2.8999	-62.3634408602	4.65	5.15	1.38	638971	2.43411442	CS
52	-7.4014	-80.8763590668	9.1515	22.35	1.38	1252470	8.95113762	CS
156	-1385.7499	-99.8738666667	1387.5	1402.425	1.38	1995831	126.71125705	CS
260	-6748.2499	-99.9740725926	6750	8182.5	1.38	1767711	328.68535296	CS

PALI - Frequently Asked Questions (FAQ)

What is the current Palisade Bio share price?

The current share price of Palisade Bio is US$ 1.7501

How many Palisade Bio shares are in issue?

Palisade Bio has 1,329,516 shares in issue

What is the market cap of Palisade Bio?

The market capitalisation of Palisade Bio is USD 2.39M

What is the 1 year trading range for Palisade Bio share price?

Palisade Bio has traded in the range of US$ 1.38 to US$ 22.35 during the past year

What is the PE ratio of Palisade Bio?

The price to earnings ratio of Palisade Bio is -0.16

What is the cash to sales ratio of Palisade Bio?

The cash to sales ratio of Palisade Bio is 8.09

What is the reporting currency for Palisade Bio?

Palisade Bio reports financial results in USD

What is the latest annual turnover for Palisade Bio?

The latest annual turnover of Palisade Bio is USD 250k

What is the latest annual profit for Palisade Bio?

The latest annual profit of Palisade Bio is USD -12.3M

What is the registered address of Palisade Bio?

The registered address for Palisade Bio is 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934

What is the Palisade Bio website address?

The website address for Palisade Bio is www.palisadebio.com.

Which industry sector does Palisade Bio operate in?

Palisade Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M